PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 51: Articles 25001-25500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Contraception and the older woman.
  2. Contraception and voluntary sterilization: male sterilization and the possibility of reversal. [Stato attuale della sterilizzazione volontaria nellambito della contraccezione: la sterilizzazione maschile e sua reversibilita.]
  3. Contraception by acrosomal proteinase inhibitors.
  4. Contraception by benzalkonium chloride ovules. [Contraception par ovules au chlorure de benzalkonium.]
  5. Contraceptive retention behaviour in rural Bangladesh.
  6. Contraceptive sterilization as a life change event: its effects upon the MMPI and CPI scales.
  7. Contraceptive sterilization in four Latin American countries.
  8. Contraceptive technology 1980-1981. 10th review ed.
  9. Contraceptive technology, 1980-1981.
  10. Contraceptive technology.
  11. Contraceptive use among teenage mothers: evaluation of a family planning program.
  12. Contraceptive use in China.
  13. Contraceptive use in Java-Bali: a multivariate analysis on the determinants of contraceptive use.
  14. Contraceptive use low: Peru women have more children than they want.
  15. Contraceptive use of cervical caps [letter]
  16. Contraceptive vaccine research: still an art.
  17. Contraceptive vaginal rings: mechanism of action and historical development.
  18. Contraceptives and feminine care products.
  19. Contraceptives available in Australia: 1980.
  20. Contraceptives must fit in reproductive life plan.
  21. Contraceptives. [Les contraceptifs.]
  22. Contraceptives: return of the condom. [Le contraceptif: retour des redingotes.]
  23. A contribution about serious ophthalmic complications with oral contraceptives (Author's transl) [Ein Beitrag uber schwerwiegende Augenschadigung durch Ovulationshemmer.]
  24. The contributions of planned parenthood to family health.
  25. Control of contraceptives.
  26. Control of physiological phenomena via hypnosis with special reference to contraception.
  27. The Copper-7 and postcoital contraception.
  28. Correlates of teenagers' contraceptive use.
  29. A cost-effectiveness analysis of the Thai family planning program.
  30. Costa Rica: family planning: a new challenge.
  31. Costs and benefits of family planning programs.
  32. Costs of medical and family planning services in an experimental outreach program.
  33. The couple, the physician and birth control. [Le couple, le medicin et la regulation des naissances.]
  34. A critical evaluation of effectiveness studies in natural family planning.
  35. Cross-cultural contraceptive decision-making. [Abstract]
  36. Cultural attitudes toward contraception: a tower of Babel.
  37. Abortion, contraceptive use, and attitudes toward pregnancy in contemporary Japan: steps toward a causal model.
  38. Abortion: the effects of contraception and motivation. A survey in Bordeaux. [L'avortement: incidence de la contraception et motivations. Une enquete a Bordeaux.]
  39. Acceptability of contraceptive methods and services: a cross-cultural perspective.
  40. Acceptability of family planning in Malaysia.
  41. Acceptability of new contraceptive technology.
  42. Acceptance and prevalence of family planning.
  43. Accommodation defects of the intrauterine contraceptive device.
  44. Achievements in family planning use.
  45. Actinomycosis and intrauterine contraceptive devices: the clinicopathologic entity.
  46. Activities in maternal-infant care and family planning: annual report, January-December 1979. Part 1. [Activites de protection materno-infantile et de planification familiale: rapport annuel, Janvier-Decembre 1979. Premiere partie.]
  47. Activities in maternal-infant care and family planning: semi-annual report, January-June 1980. [Activites de protection materno-infantile et de planification familiale: rapport semestrial, Janvier-Juin 1980.]
  48. Activities of the Special Program of Research, Training and Development in Human Reproduction, World Health Organization in the field of long acting contraceptives.
  49. Acute ischemic lesions in young women taking oral contraceptives: a report on 5 cases (author's transl) [Severite des ischemies aigues survenant chez des femmes jeunes sous contraceptifs oraux: a propos de 5 observations.]
  50. Addition to "Chen Muhua Speaks" at family planning meeting.
  51. Adenoma double the size of a man's fist of the left liver lobe and multiple adenoma of the right lobe after long-term administration of hormonal contraceptives. [Doppelmannsfaustgrosses adenom des linken leberlappens und multiple adenome im rechten leberlappen nach langzeiteinnahme hormoneller antikonzeptiva.]
  52. Administration of family planning programs.
  53. Adolescent coital and contraceptive experience in New Zealand.
  54. Adolescent contraceptive use: comparisons of male and female attitudes and information.
  55. Adolescent contraceptive use: experience in 1762 teenagers.
  56. Adolescent contraceptive users: profiles of those who succeed and those who fail. [Tables]
  57. Adolescent fertility in Latin America and the Caribbean: preliminary summary of findings from World Fertility and Contraceptive Prevalence Surveys.
  58. Adolescent girls and contraception (author's transl) [Les adolescentes et leur contraception.]
  59. Advances in female surgical contraception.
  60. Advances in intrauterine contraception.
  61. Advances in steroidal contraception.
  62. Advantages of hysteroscopy in intra-uterine contraception (author's transl) [L'interet de l'hysteresoscopie pour la contraception intra-uterine.]
  63. Adverse effects after use of oral contraceptives. A comparison. [Biverkningar vid anvandning av p-piller en jamforelse mellan 1966-70 och 1974-78.]
  64. AFP views birth control policies, practices.
  65. Agglutination, immobilization and phagocytosis of spermatozoa, and contraception development.
  66. Amenorrhea following oral contraception.
  67. Amenorrhea following oral contraception: pathophysiological problems (author's transl) [Amenorrhee apres contraception orale: problems physiopathologiques.]
  68. Amino acid losses in human sweat: influence of oral contraceptives, physical exercise and sex on the excretion of amino acids in sweat (author's transl) [Aminosaurenverluste im menschlichen schweiss: einfluss von hormoneinnahme, korperlichem training und vom geschlecht auf die aminosaurenausscheidung im schweiss.]
  69. Analysis of births averted and associated costs under the Korean National Family Planning Program; 1962-1979 (author's transl)
  70. An analysis of pharmaceutical services in family planning service sites.
  71. Analysis of serum-mediated immunosuppression in normal pregnancy, abortion and contraception.
  72. An analysis of the allocation of the resources of birth control programs.
  73. An analysis of the needs and possibilities for conducting studies on the risks and benefits of family planning in developing countries, including the Reproductive Age Mortality Survey: RAMOS.
  74. Androgens and sexual behaviour in women using oral contraceptives.
  75. Anovulation syndrome in nulligravidae following intake of hormonal contraceptives (Author's transl) [Das Syndom der Anovulation bei Nulligravidae nach Einnahme hormonaler Kontrazeptiva.]
  76. Appeals Court decision reverses former minors' contraceptive position.
  77. The application of contraceptive methods and abortion in Scandinavia. [Antikonceptionsmedelsanvaendning och aborter i Norden.]
  78. An approach to the measurement of availability of family planning services.
  79. Are combined oral contraceptives appropriate therapy for primary dysmenorrhea?
  80. Are contraceptive pills teratogenic?
  81. Artificial regulation of the generative functions of men by means of contraceptive agents. [Izkustveno regulirane na generativnite funktsii na muzha posredstvom kontratseptivni sredstva.]
  82. Aspects of birth control in nineteenth century New Zealand.
  83. Assessment of benefits and risks of oral contraceptives - 1980.
  84. Assessment of family planning - U.S./Mexico Border.
  85. An assessment of family planning and population needs in the South Pacific.
  86. Assessment of family planning: U.S./Mexico border.
  87. An assessment of population and family planning in Bolivia.
  88. The assessment of quality medical care in family-planning facilities.
  89. An assessment of the national family planning program in El Salvador.
  90. An assessment of the proposed commercial contraceptive distribution project in Sao Paulo, Brazil.
  91. Associations of birth control knowledge, attitude, and practice with mass media contact/program preference in South Teheran, Iran.
  92. Asymptomatic bacteriuria among women using oral contraceptives.
  93. Asymptomatics gonorrhoea in women attending Family Planning Clinics in Dar es Salaam, Tanzania: results of a pilot study.
  94. Attitudes of 110 married men towards family planning.
  95. Attitudes of adolescents toward pregnancy and contraception.
  96. Attitudes of family planning workers toward teenage sexual permissiveness.
  97. Attitudes of religious leaders toward family planning and abortion.
  98. Attitudes of selected secondary students toward family planning education.
  99. Attitudes towards and practice of contraception in Indore and surrounding villages.
  100. Attitudes, knowledge and the extent of use of artificial contraception in social classes 4 and 5 in Ireland.
  101. Attitudes, personal goals, and social norms as predictors of participation in child health and family planning activities in rural Southern Ghana.
  102. Audience research for improving family planning communication programs.
  103. The availability of birth control: Victoria 1971-1975.
  104. Background of humanistic family planning.
  105. Bangladesh tailors birth-control plans to fit needs.
  106. Bangladesh: family planning services in the James Finlay and Co. Tea Estates. Project description.
  107. Bangladesh: progress report of the integrated family planning, nutrition and parasite control project.
  108. The Banjar system: traditional Balinese community organization as a vehicle for family planning and nutrition education.
  109. Barrier contraception and breast cancer.
  110. Barrier contraceptives and spermicide: revealed wisdom reconsidered.
  111. Barrier contraceptives reviewed for consumer.
  112. Basaloid adenoma in the breast of woman treated with oral contraceptives.
  113. Basic statistical concepts and techniques useful for family planning research and management.
  114. Basilar artery occlusion: two angiographically demonstrated cases in young women using oral contraceptives.
  115. Benign hepatic tumors and oral contraception: pathophysiology (author's transl) [Tumeurs hepatiques benignes et contraceptifs oraux: physiopathologie.]
  116. Benign hepatoma while taking oral contraceptives (authors' transl) [Gutartige lebertumoren bei einnahme von hormonellen antikonzeptiva.]
  117. Benign tumors of the liver and oral contraceptives. [Tumeurs hepatiques benignes et contraception orale.]
  118. Billings method of contraception in adolescents. [Letter]
  119. Binding of the contraceptive steroids norgestrel and norethisterone in human plasma.
  120. Biochemical and cytochemical changes of alpha-esterases activity in long-term oral contraceptive users.
  121. Biochemical and immunological prospects for male contraception.
  122. Biochemical basis for evaluating oral contraceptives.
  123. Biochemical studies on the effect of duration of intra-uterine contraceptive device Lippes Loop on beta-glucuronidase enzyme activity in vaginal fluid and serum.
  124. Biochemical-hormonal bases for the selection of contraceptives for oral use. [Bases bioquimico-hormonales para la seleccion de anticonceptivos para uso oral.]
  125. Biodegradable drug delivery systems based on aliphatic polyesters: application to contraceptives and narcotic antagonists.
  126. Biodegradable microcapsules and microparticles for contraception.
  127. Biodegradable microsphere contraceptive system.
  128. Biomedical research on family planning in Mexico.
  129. Bird's-eye view of population and family planning in Japan.
  130. Birth control and controlling birth: women-centered perspectives.
  131. Birth control and infertility.
  132. Birth Control and sex information.
  133. Birth control in France in the eighteenth century.
  134. Birth control in India and in the People's Republic of China: a comparison of policy evolution, methods of birth control, and program organization, 1949-1974.
  135. Birth control in Latin America.
  136. Birth control in the world. [La regulation des naissances dans le monde.]
  137. Birth control program in Pakistan: a losing tortoise.
  138. Birth control technology: today and tomorrow.
  139. Birth control, abortion, and sterilization.
  140. Birth control, late marriage, and decline in the natural increase rate of population.
  141. Birth control.

     

  142. Birth control.
  143. Birth control.
  144. Birth control: foreword. [Avant-propos sur la regulation des naissances.]
  145. Birth control: new device for women who can't take the pill.
  146. Births averted among family planning acceptors in the Philippines.
  147. Births following oral contraceptive failures.
  148. Bivalent application of spermatozoal antigen in the diagnosis and treatment of immunological infertility or contraception (author's transl) [Application bivalente des antigenes de spermazoides au diagnostic et au traitement soit de la sterilite immunologique soit de la contraception.]
  149. Bleeding irregularities with steroidal contraceptives in relation to changes in circulating hormones.
  150. Blood pressure changes and oral contraceptive use: a study of 2676 black women in the southeastern United States.
  151. Body weight and cycle control of injectable contraceptives.
  152. Brazil announces family planning programme in 1981.
  153. Breast-feeding and contraception in women with hyperprolactinemia (author's transl) [L'allaitement et la contraception chez les femmes presentant une hyperprolactinemie.]
  154. Bringing surgical sterilization, the number one contraceptive method for married couples, to a low income rural population.
  155. Budd-Chiari syndrome and oral contraceptives. Report of a case and review of the literature. [Sindrome de Budd-Chiari e anticoncepcional oral relato de um caso e revisao da literatura.]
  156. Budd-Chiari syndrome following intake of oral contraceptives (author's transl) [Budd-Chiari-Syndrom hach Einnahme von Ovulationshemmern.]
  157. Budd-Chiari Syndrome in women taking oral contraceptives.
  158. Camps--an alternative delivery system for family planning service.
  159. Canadian experience with two triphasic oral contraceptive formulations.
  160. Carbohydrate and lipid metabolism: the clinical significance of the physiological changes produced by contraceptive steroids.
  161. Carbohydrate metabolism with three months of low-estrogen contraceptive use.
  162. The cardiovascular and thromboembolic risks of oral contraception: a review.
  163. Cardiovascular complications of oral contraceptives. [Pilule contraceptive et problemes cardio-vasculaires.]
  164. Cardiovascular side-effects of oral contraceptives (authors' transl) [Kardiovaskulare nebenwirkungen oraler kontrazeptiva.]
  165. Catholics agree with Protestants that abortion and contraception should be widely available.
  166. Cerebral thrombosis in woman receiving oral contraceptives: report of two cases (author's transl)
  167. Cerebral vascular occlusion and nodular hyperplasia of the liver due to oral contraceptives. [Zerebraler Gefaessverschluss und nodulaere Hyperplasie der Leber durch Ovulationshemmer.]
  168. Cerebral vein thrombosis and the contraceptive pill in paroxysmal nocturnal haemoglobinuria.
  169. Cerebrovascular accidents of arterial origin in young women (15 to 45 years) on oral contraceptives. [Accidents vasculaires cerebraux d'origine arterielle chez la femme jeune sous contraceptifs oraux (de 15 a 45 ans)]
  170. Cerebrovascular complications following intake of oral contraceptives: review of the literature apropos of a case. [Les accidents vasculaires cerebraux secondaires a la prise des contraceptifs oraux: revue de la litterature a propos d'un cas.]
  171. Cervical adenocarcinoma in users of oral contraceptives (clinical case) [Adenocarcinoma cervical en usuarias de contraceptivos orales (caso clinico)]
  172. The challenge and response: family planning in Mexico.
  173. Changes in patterns of family planning use in Colombia between 1968 and 1978: selected materials] [Tables.
  174. Changes in the carbohydrate metabolism occurring after the administration of steroid contraceptives (authors' transl) [Zmeny glycidoveho metabolismu po podavani steroidni antikoncepce.]
  175. The changing face of family planning.
  176. Characteristics of persons accepting the program of family planning of the Secretary of Health and Assistance during 1978. [Caracteristicas de las aceptantes del programa de planificacion familiar de la Secretaria de Salubridad y Asistencia durante 1978.]
  177. Characteristics of the course of periodic disease in women who use hormonal contraceptives. [Osobennosti technaiia periodichesko i bolezni u zhenshchin, primaniaiushchikh gor monal'nye kontratseptivy.]
  178. Chen Muhua, Bo Yibo speak at family planning meeting.
  179. Chest pain among oral contraceptive users.
  180. China's great fanfare on birth control.
  181. China's prospects for the 1980's: sexual restraint, birth control, the single child family, or both?
  182. Choice of a contraceptive method. [Choix d'un moyen contraceptif.]
  183. The choice of a method of contraception during adolescence. [Le choix d'une contraception au cours de l'adolescence.]
  184. Cholestatic jaundice after triacetyloleandomycin and oral contraceptives: the diagnostic value of gamma-glutamyl transpeptidase.
  185. Cholesterol cholelithiasis in adolescent females: its connection with obesity, parity, and oral contraceptive use: a retrospective study of 31 cases.
  186. Choosing a method of contraception.
  187. Chorea associated with oral contraceptive therapy.
  188. Chorea induced by oral contraceptives. [Letter]
  189. Chronic treatment with gonadotropin-releasing hormone agonist D-Ser (TBU)6-EA10-LRH for contraception in women and men.
  190. The Church and family planning.
  191. Clearance of bacteriuria on discontinuing oral contraception [letter]
  192. The client-provider interface in family planning and maternal-child health care clinics in Latin America. [Bibliography]
  193. Clinic dropout: a sociological study of three nonwhite groups of dropouts from family planning clinics. [Kliniekuitvalling: 'n sosiologiese studie van drie nie-Blanke groepe uitvallers by gesinsbeplanningsklinieke.]
  194. Clinical experience of vaginal contraceptive film containing the spermicide, polyoxyethylene nonylphenyl ether (c-film study group) (authors' transl)
  195. Clinical experience with intramuscular norethisterone oenanthate as a contraceptive.
  196. Clinical investigation of Noristerat as a depot contraceptive - Family Planning Organization of the Philippines.
  197. Clinical investigation with a new triphasic oral contraceptive.
  198. Clinical investigations with a new triphasic oral contraceptive.
  199. Clinical study results with the vaginal contraceptive preparation, traceptin. [Rezul'taty klincheskogo izucheniia vaginal 'mogo protivozachatochnogo preparata tratseptina.]
  200. Clinical survey of contraceptive effectiveness of Alpagelle, employed without a vaginal obstructor for 7322 WM (author's transl) [Etude clinique de l'efficacite contraceptive de l'Alpagelle employe sans obturatuer vaginal pendant 7322 mois.]
  201. A clinical trial of Neo Sampoon vaginal contraceptive tablets.
  202. Clomipramine and oral contraceptives: an interaction study: clinical findings.
  203. Co-occurring liver cell adenoma and focal nodular hyperplasia due to contraceptives: a case report. [Koinzidenz von leberzelladenom und fokaler nodularer hyperplasie unter ovulations hemmern: eine fallstudie.]
  204. Coagulation studies in Asian women using injectable progestogen for contraception.
  205. Coital frequency of urban couples attending family planning clinic at Bombay.
  206. Colombia: fertility down, contraceptive use up; unmet need for family planning stays unchanged.
  207. Colombia: progress report of the integrated project for family planning and parasite control.
  208. Combined clinical, histological, and stereomorphometric studies with a new oral contraceptive of normophasic type: Fysiquens.
  209. The combined use of oral medroxyprogesterone acetate and methyltestosterone in a male contraceptive trial programme.
  210. The Comilla model for family planning.
  211. Commentary: intercourse: the hidden contraceptive?
  212. Comments on the presentation of sexual distress in family planning clinics.
  213. Communicating with the family planning client.
  214. Communication about sex and birth control between mothers and their adolescent children.
  215. Communication in family planning. [Comunicacao em planejamento familiar.]
  216. Contraception by female sterilisation.
  217. Contraception by female sterilisation. [Letter]
  218. Contraception by hypnosis. [Contraccezione mediante ipnosi.]
  219. Contraception by progestational agents administered in a sequential form (author's transl) [Contraception par progestatifs administres sous forme sequentielle.]
  220. Contraception during lactation.
  221. Contraception for adolescents.
  222. Contraception for men. [La contraception masculine.]
  223. Contraception for schoolchildren: BMA welcomes minister's statement.
  224. Contraception for the insulin-dependent diabetic woman: the view from one clinic.
  225. Contraception for the young: legal restrictions.
  226. Contraception in 1980. [La contraception en 1980.]
  227. Contraception in adolescence: an overview for the pediatrician.
  228. Contraception in China.
  229. Contraception in female heart patients. [Antikontseptiia pri surdechno bolni zheni.]
  230. Contraception in Mauritius (Author's transl) [La contraception a l'ile Maurice.]
  231. Contraception in preclimacteric women with special regard to oral contraceptives (authors' transl) [Kontrazeption bei der frau im praklimakterium unter besonderer berucksichtigung der ovulationshemmer.]
  232. Contraception in risk patients: discussion. [Kontrazeption bei Risikopatientinnen: Diskussionsbemerkung.]
  233. Contraception in the adolescent: current concepts for the pediatrician.
  234. Contraception in the eighties: a theme with variations (author's transl) [Aattiotalets kontraception: ett tema med variationer.]
  235. Contraception in the light of immunological investigations (author's transl) [Antykoncepcja w swietle badan immunologicznych.]
  236. Contraception in the teenager: a comparison of four methods of contraception in adolescent girls.
  237. Contraception versus sterilization.
  238. Contraception.
  239. Contraception. [La contraception.]
  240. Contraceptive activity and mechanisms of action of combinations of a new 17alpha acetoxyprogesterone derivative and ethinyl estradiol. [Kontraseptiv haia activnost i mekanizm deistviia sochetanii novogo proizvodnogo 17 alfaatsekoksiprogesterona i etinilestradiola.]
  241. Contraceptive attitude-behavior consistency in adolescence.
  242. Contraceptive attitudes and practices: a comparison of nonpregnant college females and those with problem pregnancies.
  243. Contraceptive behavior in adolescence: a decision-making perspective.
  244. Contraceptive behaviour and fertility patterns in an inner London group practice.
  245. Contraceptive counseling for teenagers.
  246. Contraceptive decision-making: helping adolescents to choose.
  247. Contraceptive delivery systems: an evaluation of clinic vs. village in Indonesia.
  248. Contraceptive development research.
  249. Contraceptive discussion.
  250. Contraceptive distribution in Haitian villages: the initial impact.
  251. Contraceptive distribution in rural Haiti.
  252. The contraceptive effect of 6-chloro-6-deoxysugars in the male.
  253. Contraceptive effect of spermicide on cervical mucus in vivo after 24 hours (authors transl) [Etude in vivo de l'effect contraceptif sur la glaire cervicale 24 heures apres mise en place d'un spermicede.]
  254. The contraceptive effects of lactation.
  255. Contraceptive efficacy among married women aged 15-44 years, United States.
  256. Contraceptive efficacy among married women aged 15-44.
  257. The contraceptive efficacy of chlormadinone preparation (author's transl) [Badania nad efektywnoscia antykoncepcyjna chlormadinonu.]
  258. Contraceptive immunological methods. [Metodi immunologici in tema di contraccezione.]
  259. Contraceptive introduction.
  260. Contraceptive knowledge and use.
  261. Contraceptive method use by women 10-55 in California, 1976 and 1978.
  262. Contraceptive methods and sexual sensitivity. Pt. 2. [Kontrazeptionsmethoden und sexuelles Empfinden (2)]
  263. Contraceptive methods. [Metodos anticonceptivos.]
  264. Contraceptive pills and twin pregnancies. [A fogamzasgatlo tablettak es as ikerterhessegek.]
  265. Contraceptive pills and twins.
  266. Contraceptive practice and ectopic pregnancy.
  267. Contraceptive practice and trends in coital frequency.
  268. Contraceptive practice and tuboovarian abscess.
  269. The contraceptive practice of abortion patients: survey.
  270. Contraceptive prevalence survey: model questionnaire.
  271. Contraceptive Prevalence Surveys [round] 2: progress report January-June 1980.
  272. Contraceptive prevalence surveys: progress report, January-June 1980.
  273. Contraceptive Prevalence Surveys: progress report, July 1, 1979-December 31, 1979.
  274. Contraceptive retail sales program, Ghana.
  275. Contraceptive retention behavior in rural Bangladesh.
  276. Current contraceptive research.
  277. Current role of other contraceptive methods. [La place actuelle des autres methodes contraceptifs.]
  278. Current status of research on hormonal contraception in the male.
  279. Cutaneous eruptions and intrauterine contraceptive copper device.
  280. Cytological findings in oral contraceptive users among Israeli Jewish women.
  281. Cytological studies in women using different types of hormonal contraceptives.
  282. Data bases for assessing the levels of contraceptive use in developing countries: contraceptive prevalence surveys. [Tables]
  283. Databases for assessing the levels of contraceptive use in developing countries: contraceptive prevalence surveys.
  284. Debate on the use of hormonal contraceptives during lactation.
  285. Debate on the use of hormonal contraceptives during lactation.
  286. Decline in the use of oral contraceptives: psychological study of causes and backgrounds. [Der Rueckgang der Anwendung oraler Kontrazeptiva: eine psychologische Untersuchung ueber Urasachen und Hintergruende.]
  287. Decomposition of the increasing rate of contraceptive users, 1971-1979.
  288. Decomposition of the increasing rate on contraceptive users during 1971-1979 (author's transl)
  289. Decreased risk of endometrial cancer among oral-contraceptive users.
  290. Deep vein thrombosis and changes in coagulation and fibrinolysis after gynaecological operations in Chinese: the effect of oral contraceptives and malignant disease.
  291. Delivery of contraceptive services present availability of manpower to meet the needs of the community.
  292. Demand, performance, and evaluation of voluntary surgical contraception for men and women in Flanders. [Aanvraag, uitvoering en evaluatie van vrijwillige heelkundige anticonceptie bij man of vrouw in Vlaanderen.]
  293. Demographic factors and contraceptive practices of repeatedly aborting women.
  294. The demographic impact of voluntary sterilization and its relation to other birth control methods.
  295. Demographic measurement: contraceptive prevalence survey, Brazil, 1979. [Working paper]
  296. Demographic measurement: Guatemala Contraceptive Prevalence Survey, 1978.
  297. Demographic measurement: Panama Contraceptive Prevalence Survey, 1979.
  298. Demographic perspectives and contraception (author's transl) [Perspectives demographiques et contraception.]
  299. The demographic profile of clients of family planning clinics: June 1978. [Die demografiese profiel van kliente van gesinsbeplanningsklinieke: Junie 1978.]
  300. Depo-provera: contraceptive risk? [Letter]
  301. Depo-provera: some ethical questions about a controversial contraceptive.
  302. Depot gestagens as contraceptives. [Depotgestagener som kontraception.]
  303. Designing your family planning education program.
  304. Desired family size and contraceptive use.
  305. Determinants of contraceptive use in Bangladesh.
  306. The determinants of contraceptive use, reproductive goals and birth spacing in relation to mortality, breast-feeding and previous contraceptive behavior.
  307. Determination of ethinylestradiol and norethisterone in an oral contraceptive capsule by reversed-phase high performance liquid chromatography.
  308. Determination of gamma-glutamyltranspeptidase activity in the serum of healthy women taking oral contraceptives (exogenous estrogen intake). Comparison with the enzyme activity in the serum of menopausal women (reduced hormonal levels) (author's transl) [Determination de l'activite de la gamma-glutamyltranspeptidase dans le serum de femmes saines prenant des contraceptifs oraux (apport exogene d'estrogenes). Comparaison avec l'activite enzzymatique dans le serum de femmes menopausees (taux hormonal diminue)]
  309. Determination of trace elements in serum (Fe, Cu, Zn) and urine (Fe, Cu, Zn, Mn) as well as carrier proteins in hormonal contraception. [Zur Bestimmung von Spurenelementen im Serum (Fe, Cu, Zn) und Urin (Fe, Cu, Zn, Mn) sowie von Carrierproteinen bei hormonaler Kontrazeption.]
  310. Developing a population and family planning communications program for national leaders.
  311. Developing contraceptives.
  312. Development by persuasion: an integrated approach to family planning in rural India.
  313. Development of a scale to measure attitudes toward using birth control pills.
  314. Development of biodegradable contraceptive insert.
  315. Development of liver cell adenoma caused by oral contraceptives. [Leberzelltumorinduktion durch orale Kontrazeptiva.]
  316. Diet and oral contraceptive induced changes in bile cholesterol saturation and bile acid pools in healthy women.
  317. Dietary influence on the serum lipid profile of oral contraceptive (OC) users. [Abstract]
  318. Differential response by husbands and wives regarding contraceptive practice.
  319. Differentials in contraceptive knowledge in Nepal.
  320. Diffusion models for planning and evaluating family planning programs.
  321. Diffusion of family planning information among married couples: a study of two northern villages in Thailand.
  322. Dilemmas in contraceptive development: variation in endocrine response to low dose progestogens.
  323. Discussion of "The role of family planning availability and accessibility in family planning use in developing countries."
  324. Discussion of paper delivered on "The role of family planning availability and accessibility in family planning use in developing countries."
  325. Discussion of [present management of abnormal bleeding associated with steroidal contraceptives]
  326. Discussion of [vascular and perivascular changes in the endometrium of women using steroidal contraceptives]
  327. Discussion [of bleeding irregularities with steroidal contraceptives in relation to changes in circulating hormones]
  328. Discussion [of haemostatic mechanisms in the normal endometrium and endometrium exposed to contraceptive steroids]
  329. Discussion [of lysosome function in normal endometrium and endometrium exposed to contraceptive steroids]
  330. Discussion [of patterns of bleeding associated with the use of steroidal contraceptives]
  331. Discussion [of the influence of contraceptive steroids on the histochemistry and cytochemistry of the normal endometrium]
  332. Discussion: contraceptive research issues related to family planning program needs.
  333. Discussion: evaluation of new contraceptives.
  334. Discussion: long-acting steroidal contraception in the female.
  335. Discussion: luteal phase contraception.
  336. Distribution of contraception through commercial channels. [Description brochure]
  337. Distribution, intake, utilisation and effectiveness of oral contraceptive pill in rural areas of Uttar Pradesh.
  338. Dizziness associated with discontinuation of oral contraceptives in Bangladesh.
  339. Do oral contraceptives cause cancer? A review of current evidence on a subject of concern.
  340. Do oral contraceptives cause myocardial infarction? A review of current evidence on a subject of concern.
  341. Do oral contraceptives cause post-pill amenorrhea?
  342. Do's and do not's when contraception is requested after legal abortion. [Devant une demande de contraception dans le post abortum volontaire: faites....ne faites pas.]
  343. Do, do not: in the case of a request for contraception in the post-partum period. [Devant une demande de contraception dans le post partum: faites... ne faites pas.]
  344. Does use of oral contraceptives enhance the toxicity of carbon disulfide through interactions with pyridoxine and tryptophan metabolism?
  345. Domiciliary family planning -- a service described and assessed.

     

  346. Dr. Howe, et al, respond: [abortion as birth control method] [letter]
  347. Drug interaction with oral contraceptive steroids.
  348. Drug interactions with oral contraceptive steroids.
  349. Drugs, oral contraceptives and pregnancy. [Editorial]
  350. The dynamics of legal change: report of the 1980 Meeting of the Regional Law and Planned Parenthood Panel, Miami, Florida, December 8-9, 1980.
  351. An economic interpretation of the decline in fertility in a rapidly developing country: consequences of development and family planning.
  352. Education for family planning in Lesotho: evaluation of the project.
  353. Education for family planning in Mexico.
  354. Education in family planning in schools of nursing in various European countries. [Enseignement de la planification familiale dans les ecoles d'infirmieres de certain pays d'Europe.]
  355. The effect of a contraceptive attitude on marriage.
  356. Effect of a controlled exercise program on serum lipoprotein levels in women on oral contraceptives.
  357. Effect of age of pelvic inflammatory disease in nulliparous women using a copper 7 intrauterine contraceptive device.
  358. The effect of ampicillin on oral contraceptive effectiveness.
  359. The effect of contraception on breastfeeding, birth intervals, nutritional status and survival of children [thesis]
  360. The effect of contraceptives on serum lipids, gamma glutamyl transpeptidase and D-glucaric acid elimination. [Fogamzasgatlok hatasa a szerum lipidekre, a gamma-glutamyl-transzpeptidazra es a D-glukarsav uritesre.]
  361. Effect of dietary carbohydrate and use of oral contraceptives by women on serum glucose, lipid and hormone levels.
  362. The effect of hormonal contraceptive on EEG. [Vliv hormonalni antikoncepce na EEG zaznam.]
  363. The effect of hormonal contraceptives on electrolyte excretion of human parotid saliva (author's transl) [Die Auswirkungen der hormonellen Kontrazeption auf die Elektrolytausscheidung der menschlichen Ohrspeicheldruse.]
  364. Effect of HR (0-(beta-hydroxyethyl)-rutosides) on the impaired venous function of young females taking oral contraceptives: a strain gauge plethysmographic and clinical open controlled study.
  365. The effect of injectable contraceptive norethisterone enanthate on vaginal moniliasis.
  366. Effect of intrauterine contraceptives on the mitotic regimen of the endometrium (author's transl) [Vliianie vhutrimatochnykh kontratseptivov na mitoticheskii.]
  367. The effect of kind of carbohydrate in the diet and use of oral contraceptives on metabolism of young women: 2. Serum lipid levels.
  368. The effect of kind of carbohydrate in the diet and use of oral contraceptives on metabolism of young women: 3. serum glucose, insulin, and glucagon.
  369. The effect of long-term steroid contraception on coagulation in Asian women.
  370. Effect of menstrual cycle and method of contraception on recovery of Neisseria gonorrhoeae.
  371. Effect of oral contraceptive (ethinyl estradiol and d-norgestrel) on serum prolactin-oestradiol and progesterone levels.
  372. Effect of oral contraceptive agents on thiamin, riboflavin, and pantothenic acid status in young women.
  373. Effect of oral contraceptive agents on vitamin and mineral requirements.
  374. Effect of oral contraceptive cycle on dry socket (localized alveolar osteitis)
  375. The effect of oral contraceptive steroids and enzyme inducing drugs on sex hormone binding globulin capacity in women.
  376. Effect of oral contraceptives on composition and volume of breast milk.
  377. The effect of oral contraceptives on mononuclear cell cholesteryl ester hydrolase activity.
  378. Effect of oral contraceptives on the circulatory system. [Wplyw doustnych srodkow antykoncepcyjnych na uklad krazenia.]
  379. Effect of oral contraceptives on vitamin B6 nutriture of young women.
  380. Effect of oral hormonal contraceptives on hemostasis. 1. Plasma factors of coagulation. [Efecto de los anticonceptivos hormonales orales sobre la hemostasia. 1. Factores plasmaticos de la coagulacion.]
  381. THe effect of the intrauterine contraceptive device on the prevalence of morphologic abnormalities in human spontaneous abortions.
  382. Effect on prolonged use of oral contraceptive pills on the activity of serum and vaginal ribonuclease.
  383. Effectiveness and risks of contraception.
  384. Effectiveness of contraception in Flanders: results of the NEGO-III-survey 1975-1976. [Effectiviteit van de anticonceptie in Vlaanderen: resultaten van het NEGO-III-onderzoek 1975-1976.]
  385. The effectiveness of over-the-counter vaginal contraceptives.
  386. The effectiveness of the ovulation method of natural family planning: a prospective multicentre trial--the Bangalore Centre.
  387. Effects and side effects of hormonal contraceptives. [Wirkungen und Nebenwirkungen hormonaler Kontrazeptiva.]
  388. Effects of age, cigarette smoking and the oral contraceptives on the pharmacokinetics of clomipramine and its desmethyl metabolite during chronic dosing.
  389. Effects of changed contraception patterns on fertility in Taiwan: applications of a non-Markovian stochastic model.
  390. Effects of contraceptive agents on the biochemical and protein composition of human endometrium.
  391. Effects of contraceptive steroids on serum lipoproteins and cardiovascular disease scrutinized at workshop in Bethesda.
  392. The effects of education on contraceptive use in Thailand.
  393. The effects of family planning programs on fertility: a stochastic model. [Efectos de los programas de planificacion familiar sobre la fecundidad: un modelo estocastico.]
  394. Effects of hormonal contraceptives, different in composition, on the fibrin-stabilising factor (Factor 13) (authors' transl) [Die beeinflussung des fibrin stabilisierend en faktors (Faktor XIII) durch hormonale kontrazeptiva unterschiedlicher zusammensetzung.]
  395. The effects of hormonal oral contraceptives on the female human periodontium and experimental animal models, a review of the literature.
  396. Effects of limited radio/television advertising in recruiting new patients at an urban health department family planning clinic.
  397. Effects of low-dose gestagen (lynestrenol 0.5 mg) and combination type oral contraception (lynestrenol 1 mg and ethynyloestradiol 0.05 mg) on blood glucose and serum insulin levels after a glucose load.
  398. Effects of nuptiality and family planning on fertility.
  399. Effects of oestro-progestogenic oral contraceptives on blood coagulation, fibrinolysis, and platelet aggregation.
  400. Effects of oral contraceptive agents on copper and zinc balance in young women.
  401. Effects of oral contraceptive steroids on the thickness of human cornea.
  402. Effects of oral contraceptives containing 50 mcg of estrogen on blood coagulation in non-caucasian women.
  403. Effects of oral contraceptives on the liver. [Letter]
  404. Effects of pregnancy and contraceptive steroids on gall bladder function.
  405. Effects of regular exercise on serum lipids and lipoproteins in women on oral contraceptives. [Abstract]
  406. Effects on sex hormone binding globulin of different oral contraceptives containing norethisterone and lynestrenol.
  407. The efficacy of the intrauterine contraceptive devices with copper component (author's transl) [Skutecznosc Wewnatrzmacicznych Wkladek antykoncepcyjnych z dodatkiem miedzi.]
  408. Efficacy of various methods of contraception calculated on the basis of failure in applicants for termination of pregnancy in 1977 (author's transl) [Kontraceptionsmetoders effektivitet: beregnet pa grundlag af metodesvigt hos abortsogende i 1977.]
  409. The Egyptian Family Planning Program as seen by a volunteer.
  410. Elizabethan birth control and Puritan attitudes.
  411. Empirical patterns of contraceptive use: a review of the nature and sources of data and recent findings.
  412. Endometriosis: associations with menorrhagia, infertility and oral contraceptives.
  413. Enhanced prostacyclin formation in veins of women under chronical treatment with oral contraceptive drugs.
  414. The enhancement of national and family welfare through planned parenthood.
  415. Enzyme picture in the use of oral contraceptives. [Enzymmuster bei Einnahme von Kontrazeptiva.]
  416. An epidemiological study on causes of death among women of childbearing age in Taiwan: a preliminary report of the effect of oral contraceptives on cardiovascular diseases.
  417. The epididymal microenvironment: a site of attack for a male contraceptive?
  418. Epithelial melanosis of the gingiva possibly resulting from the use of oral contraceptives.
  419. Escape ovulation in women due to the missing of low dose combination oral contraceptive pills.
  420. Essay on population policy 1970-1980 (family planning) [Ensayo sobre politica de poblacion 1970-1980 (planificacion familiar)]
  421. Estimating the impact of contraceptive prevalence on fertility: aggregate and age specific versions of a model.
  422. Estimating the impact of contraceptive prevalence on fertility: aggregate and age-specific versions of a model.
  423. Estimating the need for family planning services: evidence from Contraceptive Prevalence Surveys.
  424. The estimation of costs and effectiveness of community-based family planning services.
  425. Ethinyl estradiol and conjugated estrogens as postcoital contraceptives.
  426. Ethynyl-estradiol (EE-2) content in blood and endometrium caused by oral contraceptives.
  427. An evaluation of AID-financed health and family planning projects in Nepal.
  428. An evaluation of contraceptive knowledge acquired by adolescents.
  429. An evaluation of Family Planning Assistance Through Home Economics, AHEA-AID Contract No. AID/pha-C-1178 Grant No. AID/DSPE-G-0010 Project No. 936-3006.
  430. Evaluation of family planning experimental information and education programs at Maternidad Conception Palacios, Caracas, Venezuela.
  431. Evaluation of family planning programs.
  432. Evaluation of new contraceptive: a study design.
  433. Evaluation of non verbal support materials among contraceptive acceptors in Mexico.
  434. Evaluation of the intrauterine contraceptive device. [Ocena Wewnatrzmacicznaj wkladki antykoncepcy jnej Multiload Cu 250.]
  435. Evaluation of the Mexico contraceptive retail sales program.
  436. Evaluation of the role of the public sector family planning program in the United States. [Tables]
  437. Evaluation report on the Center for Population Activities: "Training of Family Planning Managers."
  438. Evolution of contraception on current medical practice (author's transl) [Evolution de la contraception en medecine practicienne.]
  439. The evolution of family planning in Brazil.
  440. Evolution of plasma levels of apolipoprotein B, Cholesterol and triglycerides in women during long-term oral contraception.
  441. Exercise EKG and serum enzymes in women using oral contraceptives. [Belastungs-Ekg und Serumenzymverhalten bei Frauen nach Einnahme von Ovulationshemmer.]
  442. Exogenous androgens: their potential for reversible contraception.
  443. Expanding the roles of health and auxiliary personnel in family planning.
  444. The experience of the Population and Community Development Association in utilizing reward systems for contraceptive use in Thailand.
  445. Experience with norethisterone enanthate as injectable contraceptive.
  446. Experiences with the new oral contraceptive Ovysmen.
  447. Exposure to contraceptive creams, jellies and douches and their effect on the zygote [abstract]
  448. The eye and contraception. [Oeil et contraception.]
  449. Factor and typological analyses of the survey on fertility and contraception in Martinique. [Analyses factorielle et typologique de l'enquete sur la fecondite et la contraception en Martinique.]
  450. Factors affecting consumer satisfaction in family planning services in health centers, Bangkok, Thailand.
  451. Factors affecting use and non-use of contraception.
  452. Factors associated with oral contraceptive use.
  453. Factors in contraceptive decision making.
  454. Factors influencing the demand for children and their relationship to contraceptive use.
  455. Family building and family planning in pre-industrial societies.
  456. Family formation and contraception in selected developing countries: policy implications of WFS findings.
  457. Family history and oral contraceptives: unique relationship in breast cancer patients.
  458. Family planning above party politics.
  459. Family planning above party politics: proceedings of the Seminar.
  460. Family planning activities of village group midwives in Denizli Province, Turkey.
  461. Family planning and family counseling in Austria. [Pianificazione della famiglia e consultori familiari in Austria.]
  462. Family planning and freedom.
  463. Family planning and health care: what services are needed? How shall they be delivered?
  464. Family planning and immigrants.
  465. Family planning and its humanitarian background.
  466. Family planning and mental health. [La planificacion familiar y la salud mental.]
  467. Family planning and population dynamics in China. [Abstract]
  468. Family planning and tuberculosis.
  469. Family planning as a human right under the United Nations system.
  470. Family planning as a scientific mandate. [Familienplanung als wissenschaftliche Aufgabe.]
  471. Family planning as an instrument for health. [O planejamento familiar como instrumento de saude.]
  472. Family planning by couples in rural settings.
  473. The family planning clinic of CHUL: objectives, evaluation, and activities. [La clinique de planification des naissances du CHUL: objectifs, evaluation et fonctionnement.]
  474. Family planning communication approaches.
  475. Family planning counseling centers in Brazil. [Consultori per la pianificazione familiare in Brasile.]
  476. Family planning defended [India]
  477. Family planning education for pre and new literates: a guide to sources, methods and resources.
  478. Family planning funds administered by the states increased 20 percent in FY 1978.
  479. Family planning handbook for doctors. 5th ed.
  480. Family planning in a semi-rural squatter settlement in Kerala: marked preference for female sterilisation.
  481. Family planning in a Tamil village.
  482. Family planning in Brazil. [Planejamento familiar no Brazil.]
  483. Family planning in Brazil: a profile of the development of policies and programmes.
  484. Family planning in Brazil: legislation and social reality. [A consultoria para o planejamento familiar no Brasil: legislacao e realidade social.]
  485. Family planning in Chile: a profile of the development of policies and programmes.
  486. Family planning in Cuba: a profile of the development of policies and programmes.
  487. Family planning in Hong Kong: use of the IUD. [Abstract]
  488. Family planning in Mexico: a comprehensive marketing study of awareness, attitudes, and practices among consumers and retailers. [Planificacion familiar en Mexico: un extenso estudio de mercado sobre conocimiento, ectitudes y practicas entre consumidores y comerciantes.]
  489. Family planning in Mexico: a profile of the development of policies and programmes.
  490. Family planning in Nangong County.
  491. Family planning in Paraguay. [Planificacion familiar en Paraguay.]
  492. Family planning in primary care centers.
  493. Family planning in rural Egypt: a view from the health system.
  494. Family Planning in Thailand.
  495. Family planning in the People's Republic of China.
  496. Family planning in the postpartum period.
  497. Family planning in the year 2000.
  498. Family planning in Tunisia: an educational program and its implementation.
  499. Family planning manpower development: summary recommendations and training work plan developed for USAID/Morocco.
  500. Family planning manual. [Manual de planejamento familiar.]

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.